Abstract
AbstractAfrican nations have struggled to secure lifesaving COVID-19 vaccines, while rich nations have purchased more than they needed, depleting the global supply. High vaccine prices and intellectual property regulations that block the production of cheaper generics have contributed to a condition of African waithood. Hagan examines this waithood, which characterizes the disjuncture between African countries’ existential and humanitarian need for COVID-19 vaccines and corporations’ quest for profits in the pandemic. African waithood, produced by pharmaceutical companies including Moderna and Pfizer, is a direct product of colonialism. Waithood echoes the ongoing colonial relations between African nations and the corporations that continue to exploit them.
Publisher
Cambridge University Press (CUP)
Subject
Anthropology,Cultural Studies
Reference83 articles.
1. Sidibé, Michael . 2022. “Vaccine Equity: Ensuring Africa is not Left Out.” Brookings Institute. https://www.brookings.edu/blog/africa-in-focus/2022/01/24/vaccine-inequity-ensuring-africa-is-not-left-out/.
2. Waiting: elements of a conceptual framework
3. Lewis, David , and Winning, David . 2021. “Exclusive: COVID-19 shots to cost $3 to $10 under African Union vaccine plan.” https://www.reuters.com/article/us-health-coronavirus-africa-vaccine-exc/exclusive-COVID-19-shots-to-cost-3-to-10-under-african-union-vaccine-plan-idUSKBN29P0LL.
4. Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya